RING E3-ligase gp78 inhibitors (Progenra Inc)

N/A

Report date: 2025/06/11 11:01:17
NME

Base Information

Drug NameRING E3-ligase gp78 inhibitors (Progenra Inc)
Drug Alias Namereally interesting new gene E3-ligase gp78 inhibitors (Progenra)P-80152P-80142
ClassificationSmall molecules
Mechanisms of ActionUbiquitin-protein ligases inhibitorsCystic fibrosis transmembrane conductance regulator modulators
TargetsCystic fibrosis transmembrane conductance regulatorUbiquitin-protein ligases
Therapy Area/IndicationsCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProgenra Inc
China Registration ClassN/A

Develop Information

Active CompaniesProgenra Inc
Inactive CompaniesN/A
Active IndicationsCystic Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A